For instance, inhibition of CAIX or CAXII elevates peritumoral pH, enhances CD8+ T cell infiltration, and synergizes with PD-1 blockade in preclinical models of HCC and triple-negative breast cancer [337]. This evidence concerns the gene CA9 and triple-negative breast carcinoma.